Evidence map›Paper›PMID 33504099›Full record

ArticleMolecules (Basel, Switzerland)2021

Biogenic Gold Nanoparticles Decrease Methylene Blue Photobleaching and Enhance Antimicrobial Photodynamic Therapy.

Irena Maliszewska, Ewelina Wanarska, Alex C Thompson, Ifor D W Samuel, Katarzyna Matczyszyn

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Biogenic Synthesis of Gold Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. On the Photo-Eradication of Methicillin-ResistantInternational journal of molecular sciences · 2023
    Article
  13. Article
  14. Photodynamic Inactivation Effectively EradicatesJournal of fungi (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Irena MaliszewskaDepartment of Organic and Medicinal Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.ORCID 0000-0001-8702-036X
Ewelina WanarskaDepartment of Organic and Medicinal Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.
Alex C ThompsonOrganic Semiconductor Centre, SUPA, School of Physics and Astronomy, University of St Andrews, St Andrews KY16 9AJ, UK.
Ifor D W SamuelOrganic Semiconductor Centre, SUPA, School of Physics and Astronomy, University of St Andrews, St Andrews KY16 9AJ, UK.
Katarzyna MatczyszynAdvanced Materials Engineering and Modelling Group, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.
Wrocław University of Science and Technology · PLUniversity of St Andrews · GB

Funding

Funding from Polythea MSCA-ITN-EJD 764837
6 · The paper itself

Abstract

Antibiotic resistance is a growing concern that is driving the exploration of alternative ways of killing bacteria. Here we show that gold nanoparticles synthesized by the mycelium of

Indexed as

Anti-Infective AgentsDrug Resistance, MicrobialEscherichia coliGoldMetal NanoparticlesMethylene BlueMucorMyceliumOxygenParticle SizePhotobleachingPhotochemotherapyPhotosensitizing AgentsStaphylococcus aureusAnti-Infective AgentsGoldMethylene BlueOxygenPhotosensitizing Agentsantibacterial PDTantibiotic resistancebiogenic gold nanoparticlesLEDmethylene blue

Identifiers

PMID33504099
PMCPMC7865674
OpenAlexW3123904588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.